A case of pilocytic astrocytoma requiring tumor resection during pregnancy

  • Authors:
    • Toru Umehara
    • Yoshiko Okita
    • Masahiro Nonaka
    • Yonehiro Kanemura
    • Yoshinori Kodama
    • Masayuki Mano
    • Shin Nakajima
    • Toshiyuki Fujinaka
  • View Affiliations

  • Published online on: February 9, 2016     https://doi.org/10.3892/mco.2016.773
  • Pages: 567-570
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Low-grade glioma (LGG) is often encountered in relatively young individuals, including women of childbearing age. Notably, case series describing pregnant women with LGG have been reported in the literature. The present study reported a case of pilocytic astrocytoma (PA) requiring tumor resection during pregnancy. The patient had a history of γ‑knife radiotherapy for a brainstem tumor 17 years previously. The histological diagnosis was unclear. The tumor had remained stable following radiosurgery for 17 years, including during her first pregnancy. However, rapid tumor growth around the fourth ventricle occurred at week 25 of her second pregnancy. Therefore, an urgent tumor resection was performed despite the pregnancy. Partial resection was performed since the tumor had infiltrated the brainstem. The histological diagnosis was PA. The residual tumor volume decreased gradually following the delivery. Immunostaining of the tumor for the expression of progesterone receptor revealed focal staining. It is possible that reproductive factors, including specific hormonal changes during pregnancy, affected the tumor growth. The present study described this rare case of PA, which exhibited rapid growth and required urgent surgery during pregnancy.

Introduction

Low-grade glioma (LGG) is often encountered in relatively young individuals, including women of childbearing age. Advances in the therapeutic management of LGG during the last decade and improvements in its prognosis are expected to assist young women with LGG in becoming pregnant. A number of case series are found in the literature describing pregnant women with LGG, either detected prior to pregnancy or newly diagnosed during pregnancy (110). In either case, its management is a particularly challenging situation since i) anti-tumor therapy is required, although the impact on the fetus or the pregnancy would require consideration or ii) the pregnancy would have to be discontinued, depending on the severity of the disease and the gestational age (10). Once a pregnancy with LGG is identified, patients, families, and neurosurgeons must recognize that they will encounter numerous difficult decisions at each stage of the pregnancy.

The association between the behavior of the glioma and the pregnancy remains to be elucidated. Several previous studies have reported that the velocity of the diametric expansion of LGG increases during pregnancy (8) and that this acceleration may depend on multiple factors, including hormonal factors (11), growth factors (12), and hemodynamic changes (1,13), associated with pregnancy.

Pilocytic astrocytoma (PA) is typically a slow-growing astrocytoma and is therefore, considered the ‘most benign’ of all the astrocytomas. It occurs predominantly in childhood and adolescence (14). Growth of PA during pregnancy is rarely reported. The present study reported a case in which PA growth occurred and urgent resection was required during pregnancy. The behavior of the glioma is focussed on during the pregnancy.

Case report

A 30-year-old pregnant woman with a history of a brainstem tumor, which developed around the dorsal midbrain, spreading from the third to fourth ventricle was included in the present study. Although the tumor had remained pathologically undiagnosed, despite a biopsy at a previous medical institution, the patient received γ-knife therapy and ventriculoperitoneal shunt (VPS) placement at 13 years of age. The tumor remained stable following radiosurgery and the patient had undergone several VPS revisions for shunt malfunction during adolescence.

At 29-years-old, the patient became pregnant for the first time. Owing to her history of the brainstem tumor and VPS placement, she was referred to our institution at that time. She developed an eye movement disorder during the third trimester of the pregnancy, which suggested shunt malfunction due to the increased intra-abdominal pressure caused by the gravid uterus. The patient underwent a cesarean delivery (CS) and an external ventricle drain at 36 weeks of gestation under epidural anesthesia. Due to the patient's desire to bear more children in the future, an endoscopic third ventriculostomy (ETV) and to withdraw from VPS placement was planned. Therefore, two weeks following delivery, the patient underwent an ETV and an endoscopic biopsy of the residual tumor in the third ventricle. No pathological confirmation of disease was detected across several specimens. The ETV was highly effective and the VPS was removed, as planned. The post-operative course was uneventful and the patient was discharged from hospital with a healthy son. Notably, no significant changes in the behavior of the brain tumor was observed during the first pregnancy (Fig. 1).

One year later, the patient became pregnant for the second time, the patient was 30-years-old. The tumor remained stable during the first trimester (Fig. 2A). However, she presented with nausea and headache 5 months into the pregnancy. Magnetic resonance imaging (MRI) of the head revealed rapid tumor growth in the fourth ventricle and cerebellum (Fig. 2B), which necessitated an urgent resection. At the 25-week gestation point, abortion is prohibited. As fetal maturity was not sufficient to proceed with the delivery, tumor resection was performed with the patient under general anesthesia, thereby allowing the pregnancy to continue. As the tumor had infiltrated the dorsal brainstem, a partial resection was performed (Fig. 2C). The fetal heart rate was monitored and a good fetal condition was maintained during the operation. Histological examination revealed a World Health Organization grade I PA, with moderate cellularity exhibited by a number of compacted bipolar cells with Rosenthal fibers and eosinophilic granular bodies (Fig. 3A and B). Immunostaining for progesterone receptor expression revealed focal staining in the tumor (Fig. 3C). The patient had an uneventful recovery and was discharged 2 weeks after the operation. At week 37 of the pregnancy, the patient delivered a healthy daughter by CS. No complementary treatment was administered. The patient exhibited no relapse of tumor growth during the perinatal period. By contrast, the follow-up MRIs revealed a significantly decreased tumor volume by up to ~50% in just 7 months following delivery (Figs. 2D and 4).

Discussion

Glioma during pregnancy is a rare occurrence. The incidence of malignant brain tumors in pregnancy is 3.6 per million live births (15), and its management is often quite difficult. The treatment of glioma during pregnancy is complex as it may be associated with adverse effects on the fetus. If fetal pulmonary maturity has been attained, delivery prior to neurosurgery is preferable (16). Prompt therapy in parallel with the pregnancy appears to be more actively required in patients with high-grade glioma (HGG) or newly diagnosed symptomatic LGG during pregnancy compared with in patients with known LGG (kLGG) prior to pregnancy (26,9). LGG is a slow-growing tumor and the majority of pregnant women with kLGG give birth as planned and are less likely to receive any urgent therapy during pregnancy (7,8,10). Therefore, operative treatment during pregnancy for kLGG is extremely rare. However, there are, of course, exceptions to the clinical course of the disease. In a case series by Zwinkels et al (10), two pregnant women with kLGG received therapeutic abortions during the first trimester as a result of rapid tumor progression and subsequent tumor resection was performed (10). Daras et al (17) reported three cases of kLGG, which demonstrated neurological deterioration during pregnancy or puerperium due to malignant transformation of LGG to HGG. Of these, one patient underwent a tumor resection at 24 weeks of gestation during her pregnancy and the other two received radiation and chemotherapy following the gestation period. In the present case, no option was available other than urgent surgical treatment and the continuation of the pregnancy as the patient presented with neurological deterioration associated with tumor growth and fetal maturity had not been achieved.

PA is a circumscribed, slow-growing, benign astrocytoma that occurs predominantly in childhood and adolescence (14). Despite an extensive literature search, only one report of a PA associated with pregnancy exists and it had required tumor resection (6). The PA in this case was newly diagnosed during pregnancy and surgery was performed shortly after delivery (6). By contrast, the PA in our case was observed carefully for 17 years and the tumor volume remained stable until the patient's second pregnancy. Despite careful observation, rapid tumor growth occurred during the second pregnancy and tumor resection was performed during the pregnancy. Although tumor growth of PA during pregnancy is extremely rare, neurosurgeons should maintain careful observation when young women with PAs are considering becoming pregnant.

The mechanism by which pregnancy affects glioma has remained unclear. Pregnancy leads to major changes in the levels of pregnancy hormones. Progesterone levels are dramatically elevated during a pregnancy, particularly during the later stages (18). Gonzalez-Aguero et al (11) reported that progesterone induces cell growth in human astrocytomas (11). Khalid et al (19) suggested that progesterone receptors may be involved in the growth of astrocytic tumors (19). In the present case, immunostaining for the expression of progesterone receptor revealed focal staining in the tumor. Symptomatic appearance in our patient began at 5 months into the pregnancy, and the tumor volume significantly decreased following delivery. It is possible that changes in progesterone levels induced progesterone receptor activation and affected tumor growth and regression in our patient.

In conclusion, the present study reported a case of PA, which exhibited progression and required urgent neurosurgical treatment during the patient's second pregnancy. While this was an extremely rare event, the changes in progesterone levels during pregnancy may have induced progesterone receptor activation and affected tumor growth. Neurosurgeons and obstetricians should recognize the possibility of tumor progression during each pregnancy and the necessity of close neurological follow-up with repeated MRIs and obstetrical monitoring, even if the histological type is not typically malignant and no observable tumor growth occurs during previous pregnancies. The present study is an important clinical case of a brain tumor during pregnancy, which gives cause for alarm.

References

1 

Blumenthal DT, Parreño MG, Batten J and Chamberlain MC: Management of malignant gliomas during pregnancy: A case series. Cancer. 113:3349–3354. 2008. View Article : Google Scholar : PubMed/NCBI

2 

Cohen-Gadol AA, Friedman JA, Friedman JD, Tubbs RS, Munis JR and Meyer FB: Neurosurgical management of intracranial lesions in the pregnant patient: A 36-year institutional experience and review of the literature. J Neurosurg. 111:1150–1157. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Isla A, Alvarez F, Gonzalez A, García-Grande A, Perez-Alvarez M and García-Blazquez M: Brain tumor and pregnancy. Obstet Gynecol. 89:19–23. 1997. View Article : Google Scholar : PubMed/NCBI

4 

Johnson N, Sermer M, Lausman A and Maxwell C: Obstetric outcomes of women with intracranial neoplasms. Int J Gynaecol Obstet. 105:56–59. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Lynch JC, Gouvêa F, Emmerich JC, Kokinovrachos G, Pereira C, Welling L and Kislanov S: Management strategy for brain tumour diagnosed during pregnancy. Br J Neurosurg. 25:225–230. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Nishio S, Morioka T, Suzuki S, Takeshita I, Ikezaki K, Fukui M and Nakano H: Primary brain tumours manifesting during pregnancy: Presentation of six cases and a review of the literature. J Clin Neurosci. 3:334–337. 1996. View Article : Google Scholar : PubMed/NCBI

7 

Pallud J, Duffau H, Razak RA, Barbarino-Monnier P, Capelle L, Fontaine D, Frenay M, Guillet-May F, Mandonnet E and Taillandier L: Influence of pregnancy in the behavior of diffuse gliomas: Clinical cases of a French glioma study group. J Neurol. 256:2014–2020. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Pallud J, Mandonnet E, Deroulers C, Fontaine D, Badoual M, Capelle L, Guillet-May F, Page P, Peruzzi P and Jouanneau E: Pregnancy increases the growth rates of World Health Organization grade II gliomas. Ann Neurol. 67:398–404. 2010.PubMed/NCBI

9 

Sneed PK, Albright NW, Wara WM, Prados MD and Wilson CB: Fetal dose estimates for radiotherapy of brain tumors during pregnancy. Int J Radiat Oncol Biol Phys. 32:823–830. 1995. View Article : Google Scholar : PubMed/NCBI

10 

Zwinkels H, Dörr J, Kloet F, Taphoorn MJ and Vecht CJ: Pregnancy in women with gliomas: A case-series and review of the literature. J Neurooncol. 115:293–301. 2013. View Article : Google Scholar : PubMed/NCBI

11 

González-Agüero G, Gutiérrez AA, González-Espinosa D, Solano JD, Morales R, González-Arenas A, Cabrera-Muñoz E and Camacho-Arroyo I: Progesterone effects on cell growth of U373 and D54 human astrocytoma cell lines. Endocrine. 32:129–135. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Schlenska-Lange A, Knüpfer H, Lange TJ, Kiess W and Knüpfer M: Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro. Anticancer Res. 28:1055–1060. 2008.PubMed/NCBI

13 

Ducray F, Colin P, Cartalat-Carel S, Pelissou-Guyotat I, Mahla K, Audra P, Gaucherand P, Honnorat J and Trouillas P: Management of malignant gliomas diagnosed during pregnancy. Rev Neurol (Paris). 162:322–329. 2006.(In French). View Article : Google Scholar : PubMed/NCBI

14 

Huang H, Hara A, Homma T, Yonekawa Y and Ohgaki H: Altered expression of immune defense genes in pilocytic astrocytomas. J Neuropathol Exp Neurol. 64:891–901. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Haas JF, Jänisch W and Staneczek W: Newly diagnosed primary intracranial neoplasms in pregnant women: A population-based assessment. J Neurol Neurosurg Psychiatry. 49:874–880. 1986. View Article : Google Scholar : PubMed/NCBI

16 

Tewari KS, Cappuccini F, Asrat T, Flamm BL, Carpenter SE, Disaia PJ and Quilligan EJ: Obstetric emergencies precipitated by malignant brain tumors. Am J Obstet Gynecol. 182:1215–1221. 2000. View Article : Google Scholar : PubMed/NCBI

17 

Daras M, Cone C and Peters KB: Tumor progression and transformation of low-grade glial tumors associated with pregnancy. J Neurooncol. 116:113–117. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Li R, Scanlon KS and Serdula MK: The validity and reliability of maternal recall of breastfeeding practice. Nutr Rev. 63:103–110. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Khalid H, Shibata S, Kishikawa M, Yasunaga A, Iseki M and Hiura T: Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Cancer. 80:2133–2140. 1997. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April-2016
Volume 4 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Umehara T, Okita Y, Nonaka M, Kanemura Y, Kodama Y, Mano M, Nakajima S and Fujinaka T: A case of pilocytic astrocytoma requiring tumor resection during pregnancy. Mol Clin Oncol 4: 567-570, 2016
APA
Umehara, T., Okita, Y., Nonaka, M., Kanemura, Y., Kodama, Y., Mano, M. ... Fujinaka, T. (2016). A case of pilocytic astrocytoma requiring tumor resection during pregnancy. Molecular and Clinical Oncology, 4, 567-570. https://doi.org/10.3892/mco.2016.773
MLA
Umehara, T., Okita, Y., Nonaka, M., Kanemura, Y., Kodama, Y., Mano, M., Nakajima, S., Fujinaka, T."A case of pilocytic astrocytoma requiring tumor resection during pregnancy". Molecular and Clinical Oncology 4.4 (2016): 567-570.
Chicago
Umehara, T., Okita, Y., Nonaka, M., Kanemura, Y., Kodama, Y., Mano, M., Nakajima, S., Fujinaka, T."A case of pilocytic astrocytoma requiring tumor resection during pregnancy". Molecular and Clinical Oncology 4, no. 4 (2016): 567-570. https://doi.org/10.3892/mco.2016.773